NEW YORK (GenomeWeb) – Diamir today announced that it has received a two-year grant from the National Institutes of Health to further develop its microRNA-based diagnostic for Alzheimer's disease and its precursor, mild cognitive impairment (MCI).

Founded in 2009, Diamir's core technology involves the detection and analysis of miRNAs in plasma, and the company has thus far been focused on linking miRNA signatures with neurodegenerative conditions such as Alzheimer's and Parkinson's diseases.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Berkeley researchers have engineered yeast to make the molecule behind the hoppy taste of beer, Quartz reports.

King's College London researchers examine the influence of school type and genetics on academic achievement.

FiveThirtyEight writes that most who take a direct-to-consumer BRCA1/2 genetic test won't learn much from it.

In Science this week: early life experience influence somatic variation in the genome, and more.